Sunday, December 07, 2025 | 04:17 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

USTR discusses proposed IP rights waiver with Pfizer, AstraZeneca

Development comes a day after US President Joe Biden said he is determined to help India in its time of need

Katherine Tai
premium

US Trade Representative Katherine Tai

Shreya Nandi New Delhi
The US Trade Representative (USTR) Katherine Tai met top vaccine makers to discuss the proposed waivers to some provisions of the World Trade Organization’s (WTO’s) Trade Related Aspects of Intellectual Property Rights (TRIPS) agreement in light of Covid-19.
 
“Earlier today, Ambassador Tai continued her engagement with stakeholders on vaccine production and global health issues. She met virtually with executives from Pfizer and AstraZeneca about increasing global vaccine production and the proposed TRIPS waiver. Tai emphasised her commitment to working with WTO members on a global pandemic response that addresses critical gaps in global vaccine production and distribution,” a USTR